Advertisement
Research ArticleCellular and Molecular

Survivin Inhibitor YM-155 sensitizes TRAIL-resistant Glioma Cells to Apoptosis through Mcl-1 Down-regulation and by engaging the mitochondrial death pathway

Daniel R Premkumar, Esther P Jane, Kimberly A Foster and Ian F Pollack
Journal of Pharmacology and Experimental Therapeutics June 5, 2013, jpet.113.204743; DOI: https://doi.org/10.1124/jpet.113.204743

Article Information

jpet.113.204743
DOI 
https://doi.org/10.1124/jpet.113.204743
PubMed 
23740602
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online June 5, 2013.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Daniel R Premkumar,
  2. Esther P Jane,
  3. Kimberly A Foster, and
  4. Ian F Pollack*
  1. University of Pittsburgh
  1. ↵* Corresponding author; email: daniel.premkumar{at}chp.edu

Statistics from Altmetric.com

Article usage

Article usage: June 2013 to December 2024

AbstractFullPdf
Jun 20132041110
Jul 20133791696
Aug 20132552952
Sep 20131152029
Oct 2013862725
Nov 2013641018
Dec 20134999
Jan 2014591617
Feb 2014261012
Mar 2014391515
Apr 20144558
May 2014271615
Jun 20141787
Jul 2014221816
Aug 201418914
Sep 2014132611
Oct 201413126
Nov 2014112014
Dec 201411155
Jan 2015161612
Feb 2015131521
Mar 2015261610
Apr 2015171510
May 2015122012
Jun 201532912
Jul 2015112117
Aug 20157169
Sep 201513134
Oct 2015562
Nov 20151275
Dec 201511115
Jan 2016191611
Feb 2016765
Mar 201610117
Apr 20165142
May 201616115
Jun 201619134
Jul 201620165
Aug 201624209
Sep 201613186
Oct 201614339
Nov 201696418
Dec 2016816636
Jan 2017012314
Feb 20170383
Mar 201703811
Apr 20170295
May 20172399
Jun 20172328
Jul 20170286
Aug 20173358
Sep 201722240
Oct 201712412
Nov 20170324
Dec 20172279
Jan 20181174
Feb 20181328
Mar 201803311
Apr 20184349
May 20182384
Jun 201804711
Jul 20180368
Aug 20187237
Sep 20180192
Oct 201801719
Nov 201801513
Dec 20181464
Jan 20191404
Feb 20191200
Mar 20191332
Apr 20191605
May 20191530
Jun 2019516
Jul 20191425
Aug 20192610
Sep 20191710
Oct 20191502
Nov 20192133
Dec 20191300
Jan 2020603
Feb 2020811
Mar 2020600
Apr 20201603
May 2020800
Jun 2020400
Jul 2020902
Aug 2020401
Sep 2020932
Oct 2020611
Nov 20201201
Dec 20201800
Jan 2021711
Feb 20211152
Mar 20211831
Apr 2021812
May 2021721
Jun 20211430
Jul 2021922
Aug 20211022
Sep 2021511
Oct 2021510
Nov 20211310
Dec 202117511
Jan 202212210
Feb 20221512
Mar 2022910
Apr 2022935
May 20221911
Jun 2022812
Jul 20222010
Aug 20224837
Sep 20221514
Oct 20221640
Nov 20223943
Dec 2022812
Jan 20231120
Feb 20231115
Mar 20231311
Apr 20231612
May 20231911
Jun 20231730
Jul 20231912
Aug 2023510
Sep 2023620
Oct 20231108
Nov 20232020
Dec 20232940
Jan 20246921
Feb 20241110
Mar 20241010
Apr 20242842
May 20243443
Jun 20245832
Jul 20242630
Aug 20242331
Sep 20243114
Oct 20241910
Nov 20241401
Dec 20241321

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleCellular and Molecular

Survivin Inhibitor YM-155 sensitizes TRAIL-resistant Glioma Cells to Apoptosis through Mcl-1 Down-regulation and by engaging the mitochondrial death pathway

Daniel R Premkumar, Esther P Jane, Kimberly A Foster and Ian F Pollack
Journal of Pharmacology and Experimental Therapeutics June 5, 2013, jpet.113.204743; DOI: https://doi.org/10.1124/jpet.113.204743
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement